Authors/Disclosures
|
Roi A. Wallis, MD
|
No disclosure on file |
|
Shishir K. Rao, MD
(Wellstar Health Sciences)
|
The institution of Dr. Rao has received research support from Eisai, Inc. |
|
Kimberly L. Panizzon
|
No disclosure on file |
|
Kushak Suchdev, MD
(Boston School of Medicine, Neurology)
|
Dr. Suchdev has nothing to disclose. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Lucia Moiola, MD, PhD
(Fondazione Centro San Raffaele)
|
Dr. Moiola has nothing to disclose. |
|
Dennis Parker Jr.
|
No disclosure on file |
|
|
No disclosure on file |
|
Kumar Rajamani, MD, FAAN
|
Dr. Rajamani has nothing to disclose. |
|
Wazim Mohamed, MD
(Detroit Medical Center/Wayne State University)
|
Dr. Mohamed has nothing to disclose. |
|
David A. Wolk, MD, FAAN
(University of Pennsylvania)
|
Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Wolk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. The institution of Dr. Wolk has received research support from Biogen. Dr. Wolk has received publishing royalties from a publication relating to health care. Dr. Wolk has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Eli Lilly. |